Global Hemp : GHG Welcomes Christopher Cherry as its New CFO

About this update from Global Hemp Group, Inc.

2024 Aug 23_24 - GHG Welcomes New CFO May 29_24 - GHG Increases PP Size Apr9_24 - GHG Provides MCTO Update Mar26_24 - GHG Provides MCTO Update Mar12_24 - GHG Provides MCTO Update Feb21_24 - GHG Welcomes Louis Rene Vallee Feb27_24 - GHG Provides MCTO Update Feb14_24 - GHG Provides Update on its Industrial Hemp Division Feb13_24 - GHG Provides MCTO Update Jan 31_24 - GHG Announces Closing of Debt Settlement Jan 30_24 - GHG Announces MCTO Jan 26_24 - GHG Closes 1st Tranche PP, issue Opt Agr Shrs Jan 16_24 - GHG Announces PP Jan 15_24 - GHG Executes Option Agr and Announces PP Jan 11_24 - GHG Appoints Yousef Kamhiyah CFO Global Hemp Group Welcomes Christopher Cherry as its New CFO Vancouver, BC -- (August 23, 2024) -- GLOBAL HEMP GROUP INC. ("GHG" or the "Company") ( CSE: GHG / OTC: GBHPF / FRANKFURT: GHG0 ) is pleased to welcome Christopher Cheery, CPA, CGA as its new CFO, replacing the company's current CFO Yousef Kamhiyah. Mr. Christopher Cherry has over 20 years of corporate accounting and audit experience, along with extensive corporate experience, having held senior level positions for several public mining companies including Director, Chief Financial Officer, and Secretary. Mr. Cherry is a CPA having obtained the Chartered Accountant designation in February 2009 and the Certified General Accountant designation in 2004. In his former experience as an auditor, he held positions with KPMG and Davidson and Co. LLP in Vancouver, where he gained experience as an auditor for junior public companies, and an IPO specialist. About Global Hemp Group Inc. Global Hemp Group Inc. ( CSE: GHG / OTC: GBHPF / FRANKFURT: GHG0 ) is currently focused on two key business segments - Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp division's primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. The Health and Wellness Division is focused on the acquisition of exclusive licensing of patents and IP. For Further Information Contact Global Hemp Group Investor Relations Tel: 778-726-2900 [email protected] https://www.globalhempgroup.com Cautionary Note Regarding Forward Looking Statements Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise. The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

View stock analysis, news, and events for Global Hemp Group, Inc.